[Epigenetic modification as a therapeutic approach for B-cell lymphoma]
Momoko Nishikori1, Akifumi Takaori-Kondo1
1Department of Hematology/Oncology, Graduate School of Medicine, Kyoto University.
Summary
Tazemetostat, an EZH2 inhibitor, shows promise in treating follicular lymphoma by restoring immune gene expression and enhancing anti-tumor immunity. This epigenetic therapy may also impact Hodgkin lymphoma by modulating the tumor microenvironment.
Area of Science:
- Immunology
- Epigenetics
- Oncology
Background:
- Epigenetic modifications regulate immune gene expression during B cell development.
- Mutations in epigenetic modifiers like EZH2 are implicated in follicular lymphoma pathogenesis.
- Tazemetostat is an approved EZH2 inhibitor for specific follicular lymphoma cases.
Purpose of the Study:
- To investigate the effects of tazemetostat on immune gene expression and cellular interactions in lymphoma.
- To explore the potential of tazemetostat in modulating the tumor microenvironment, particularly in Hodgkin lymphoma.
Main Methods:
- Analysis of gene expression changes induced by tazemetostat.
- Assessment of immune cell responses (T cells, NK cells) to tazemetostat-treated lymphoma cells.
- Evaluation of chemokine secretion and cell migration patterns.
Main Results:
- Tazemetostat restores MHC and CD58 expression in lymphoma cells.
- It enhances T and NK cell-mediated anti-lymphoma immunity.
- Tazemetostat induces CCL17/TARC secretion, promoting T-cell migration and potentially influencing the Hodgkin lymphoma microenvironment.
Conclusions:
- Tazemetostat demonstrates immunomodulatory effects beyond its direct anti-cancer activity.
- Epigenetic therapies like tazemetostat offer new therapeutic avenues for lymphomas.
- Understanding epigenetic mechanisms is crucial for deciphering lymphoma pathogenesis and histology.
Related Concept Videos
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
01:37Epigenetic Regulation
3.2K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.2K
01:32Chromatin Modification in iPS Cells
1.9K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.9K
01:27Tumor Immunotherapy
687
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
687
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:24Methods of Nuclear Reprogramming
1.9K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.9K